Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2

2(40.0%)

N/A

2(40.0%)

Phase 3

1(20.0%)

5Total

Phase 2(2)

N/A(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT00116220Phase 3Completed

Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer

Role: collaborator

NCT00545792Phase 2Completed

Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers

Role: collaborator

NCT02873572Not ApplicableUnknown

Vulnerability Markers in Pathological Gambling

Role: collaborator

NCT01607424Not ApplicableCompleted

Specific Cognitive Remediation for Schizophrenia

Role: collaborator

NCT00134654Phase 2Completed

Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer

Role: collaborator

All 5 trials loaded